Percipio Health
AI NativePopulation Health Monitoring & Management
Est 2022|Valuation $3M|Raised $21M
Population Health Monitoring & Management
Published Jul 24, 2026
No detailed public product roadmap was located in this research.
Not documented publicly in available materials.
Percipio Health’s site includes testimonials such as a statement from Oklahoma State University Center for Health Sciences leadership describing the partnership and referring to an AI-enabled app that provides a real-time snapshot of individual and community health (testimonial hosted on vendor site).
Interpretation: vendor-hosted testimonials are curated content and represent selected partner perspectives; they are not independent third-party reviews.
Interpretation: while the App Store ratings are positive, the sample size is small and likely subject to selection bias; App Store feedback alone is weak evidence for enterprise procurement decisions.
Because most accessible quotes labeled "Percipio" relate to Skillsoft rather than Percipio Health, this report omits cross-product quotes to avoid confusion.
The vendor highlights a partnership with Oklahoma State University (testimonial and related posts). Publicly available materials in this research did not include rigorous outcome metrics (for example, admissions avoided, engagement rates, or PMPM reduction) attributable to Percipio Health in peer-reviewed or audited form.
Get a comprehensive analysis of Percipio Health including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →You need regulated, device-based physiological monitoring with strong validation If clinical governance requires FDA-cleared devices for vitals and peer-reviewed validation, smartphone-derived signals are likely insufficient unless the vendor provides robust evidence and regulatory attestation.
Your procurement requires public-facing security documentation If the security review process expects a publicly documented security page with certifications, penetration test summaries, and a subprocessor list, additional diligence work will be required to obtain those artifacts from the vendor.
You need transparent, self-serve pricing If a smaller provider group needs immediate budgetary pricing without a sales cycle, vendors that publish pricing (more common in SMB telehealth than enterprise payer tools) may be easier to evaluate.
You require mature third-party review coverage If third-party review volume and independent product review sources are a key part of the selection criteria, Percipio Health has a limited product-specific footprint publicly; reference calls and pilots will be more important.
A significant challenge in this research is that "Percipio" is also the name of Skillsoft’s learning platform, which dominates review platforms and social discussions. Many third-party review pages and forum posts reference Skillsoft’s Percipio rather than Percipio Health.
To avoid misleading conclusions:
The vendor publishes impact-style metrics and example scenarios, including a vendor-modeled scenario estimating a multi-million-dollar annual cost-of-care reduction for a hypothetical cohort and a vendor-claimed large reduction in technology costs compared to device-based RPM.
Critical evaluation: these are vendor-modeled estimates that depend on multiple assumptions (for example, engagement rates, risk mix, baseline costs, and intervention efficacy). The public presentation does not include a full methodology or sensitivity analysis. It is advisable to request the actuarial model, sensitivity analyses, and any third-party validation when evaluating vendor claims.
Percipio Health is a population health monitoring and management platform that uses a smartphone app (described by the vendor as "device-free") to collect multiple health signals (for example, vitals via phone camera, voice-based cognitive/"brain health" indicators, medication adherence, and social needs/SDOH). It combines ongoing engagement, machine learning–based risk stratification, and decision support to help payers and providers identify rising risk earlier and operationalize interventions at scale. The vendor positions the product as broader in scope than traditional remote patient monitoring (RPM), targeting not only the highest-risk patients but also populations identified as "rising risk."
Based on the vendor’s website and launch materials, Percipio Health primarily targets:
Positioning: a hybrid between population health management and remote patient monitoring, with an emphasis on lower technology and logistics costs relative to device-based RPM and on earlier identification of rising risk and support for clinical workflows rather than clinician replacement.